Combined Application Value of Chromosome Karyotype Analysis and Chromosomal Microarray Analysis (CMA) in Prenatal Diagnosis
Main Article Content
Abstract
Objective: Chromosome karyotype analysis is the gold standard for prenatal diagnosis yet carries multiple limitations. Chromosomal microarray analysis (CMA) can overcome these drawbacks to a certain extent. This study aims to evaluate the clinical application value of combined chromosome karyotype analysis and CMA in the diagnosis of fetal chromosomal abnormalities in Yancheng. Methods: Retrospectively analyze amniotic fluid test results collected from January 2020 to December 2023, with combined detection of chromosome karyotype analysis and CMA performed on all specimens. Results: The positive detection rate of combined karyotype and CMA testing reached 21.70%. Cases included 159 aneuploidies, 27 mosaic aneuploidies, 19 balanced chromosomal abnormalities, 46 pathogenic or likely pathogenic copy number variations (CNVs), and 51 variants of uncertain clinical significance (VUS). Conclusion: Combined application of CMA and chromosome karyotype analysis is recommended for prenatal diagnosis to elevate positive detection rates, provide scientific and accurate genetic diagnosis, and improve the quality of prenatal genetic counseling.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
L. Y. Sun, Q. H. Xing, and L. He, “Retrospect and Prospect of Genetic Research on Birth Defects in China [M],” 2018.
Y. Zheng, Z. Zhong, Y. Zhao, et al., “Comparative analysis of the application with the combination of CMA and karyotype in routine and late amniocentesis,” Archives of Gynecology and Obstetrics, 2024.
S. Z. Qu, P. L. Shi, T. Y. Zhang, et al., “Application of CNV-seq and chromosome karyotype analysis in prenatal diagnosis of balanced translocation carriers,” Chinese Journal of Birth Health & Heredity, vol. 39, no. 4, 2022.
G. Qian, L. Cai, H. Yao, et al., “Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators,” BMC Pregnancy and Childbirth, vol. 23, no. 1, 784, 2023.
L. Carbone, F. Cariati, L. Sarno, et al., “Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges,” Genes, vol. 12, no. 1, 2020.
H. Ling, “Ministry of Health releases National Report on Birth Defect Prevention (2012),” China Modern Medicine, vol. 19, no. 28, p. 1, 2012.
R. J. Lipinski and R. S. Krauss, “Gene-environment interactions in birth defect etiology: Challenges and opportunities,” Current Topics in Developmental Biology, vol. 152, pp. 1–30, 2023.
H. L. Duan, W. J. Wang, Y. Zhang, et al., “Clinical practice of prenatal screening based on cell-free fetal DNA in maternal peripheral blood,” Chinese Journal of Medical Genetics, vol. 39, no. 3, pp. 264–268, 2022.
X. X. Tian, X. L. Wan, H. M. Weng, et al., “Application effect of whole-process nursing combined with emotional nursing in pregnant women undergoing amniocentesis,” Clinical Research, vol. 32, no. 06, pp. 172–175, 2024.
X. Han, J. Ran, C. X. Niu, et al., “Analysis of the influence of psychological counseling on pregnant women receiving amniocentesis,” Health Vocational Education, vol. 36, no. 04, pp. 158–159, 2018.
Y. Xia, Yeerdengqiqieke, Jamila Rezhake, et al., “Study on the correlation between prenatal diagnostic indications of amniocentesis and fetal chromosome karyotype of amniotic fluid,” Chinese Journal of Birth Health & Heredity, vol. 27, no. 03, pp. 292–293, 2019.
Y. Hu, W. Liu, G. He, et al., “Clinical utility of expanded NIPT for chromosomal abnormalities and etiology analysis of cytogenetic discrepancies cases,” Journal of Assisted Reproduction and Genetics, vol. 39, no. 1, pp. 267–279, 2022.
Y. Li, X. Yang, Y. Zhang, et al., “The detection efficacy of noninvasive prenatal genetic testing (NIPT) for sex chromosome abnormalities and copy number variation and its differentiation in pregnant women of different ages,” Heliyon, vol. 10, no. 2, e24155, 2024.
G. M. Eggenhuizen, S. Van Veen, N. Van Koetsveld, et al., “Confined placental mosaicism: Distribution of chromosomally abnormal cells over the term placenta,” Placenta, vol. 154, pp. 60–65, 2024.
X. Q. Wu, H. L. Huang, X. M. Chen, et al., “Influence of confined placental mosaicism on non-invasive prenatal testing and clinical analysis,” Chinese Journal of Medical Genetics, vol. 38, no. 4, pp. 335–338, 2021.
L. Dugoff, M. E. Norton, and J. A. Kuller, “The use of chromosomal microarray for prenatal diagnosis,” American Journal of Obstetrics and Gynecology, vol. 215, no. 4, pp. B2–B9, 2016.
S. Zhang, Y. Xu, D. Lu, et al., “Combined use of karyotyping and copy number variation sequencing technology in prenatal diagnosis,” PeerJ, vol. 10, e14400, 2022.
J. A. Rosenfeld, M. E. Tucker, L. F. Escobar, et al., “Diagnostic utility of microarray testing in pregnancy loss,” Ultrasound in Obstetrics & Gynecology, vol. 46, no. 4, pp. 478–486, 2015.
J. Wang, D. Wang, Y. Yin, et al., “Assessment of Combined Karyotype Analysis and Chromosome Microarray Analysis in Prenatal Diagnosis: A Cohort Study of 3710 Pregnancies,” Genetics Research, vol. 2022, 6791439, 2022.
M. Hao, L. Li, H. Zhang, et al., “The difference between karyotype analysis and chromosome microarray for mosaicism of aneuploid chromosomes in prenatal diagnosis,” Journal of Clinical Laboratory Analysis, vol. 34, no. 12, e23514, 2020.
K. Markus-Bustani, Y. Yaron, M. Goldstein, et al., “Undetected sex chromosome aneuploidy by chromosomal microarray,” Prenatal Diagnosis, vol. 32, no. 11, pp. 1117–1118, 2012.
X. Zhao, M. Zhang, A. N. Jia, et al., “Application value of fluorescence in situ hybridization in prenatal diagnosis,” Chinese Journal of Birth Health & Heredity, vol. 26, no. 02, pp. 31–32, 45, 2018.
Genetic Disease Prevention Group of Birth Defect Prevention and Control Professional Committee of Chinese Preventive Medicine Association, Medical Genetics Branch of Chinese Medical Association, Prenatal Diagnosis Professional Committee of Chinese Physician Association Genetic Physician Branch, et al., “Expert consensus on the application of genome copy number variation detection in products of conception and family reproductive counseling,” Chinese Journal of Medical Genetics, vol. 40, no. 2, pp. 129–134, 2023.